Is Family Care overvalued or undervalued?
As of October 17, 2025, Family Care is fairly valued with a PE ratio of 0.79 and an EV to EBITDA of 0.95, indicating strong profitability compared to peers like Max Healthcare and Apollo Hospitals, despite a year-to-date stock decline of 35.14% against the Sensex's 7.44% gain, suggesting potential for recovery in the healthcare sector.
As of 17 October 2025, the valuation grade for Family Care has moved from expensive to fair, indicating a shift in perception regarding its market value. The company is currently fairly valued, with a PE ratio of 0.79, an EV to EBITDA of 0.95, and an impressive ROE of 219.63%. These ratios suggest that Family Care is positioned well in terms of profitability and efficiency compared to its peers.In comparison to its industry peers, Family Care's valuation metrics stand out. For instance, Max Healthcare is categorized as very expensive with a PE ratio of 97.05, while Apollo Hospitals is also fairly valued with a PE of 72.25. This highlights Family Care's relative attractiveness in the market. Despite recent stock performance lagging behind the Sensex, particularly a YTD decline of 35.14% compared to the Sensex's gain of 7.44%, the current valuation suggests potential for recovery and growth in the healthcare services sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
